USD 66.1
(-2.79%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 58.59 Million USD | -6.5% |
2022 | 62.66 Million USD | -5.27% |
2021 | 66.15 Million USD | 14.68% |
2020 | 57.68 Million USD | 24.42% |
2019 | 46.36 Million USD | 17.43% |
2018 | 39.47 Million USD | 10.01% |
2017 | 35.88 Million USD | -1.96% |
2016 | 36.6 Million USD | 10.72% |
2015 | 33.06 Million USD | 14.25% |
2014 | 28.93 Million USD | 34.09% |
2013 | 21.57 Million USD | 6.81% |
2012 | 20.2 Million USD | 0.0% |
2010 | 23.29 Million USD | -2.04% |
2009 | 23.78 Million USD | 0.0% |
2006 | 21.86 Million USD | 12.81% |
2005 | 19.38 Million USD | 4.6% |
2004 | 18.53 Million USD | 11.84% |
2003 | 16.57 Million USD | 17.26% |
2002 | 14.13 Million USD | 0.0% |
2000 | 12.25 Million USD | 5.08% |
1999 | 11.66 Million USD | 5.22% |
1998 | 11.08 Million USD | 11.69% |
1997 | 9.92 Million USD | 11.02% |
1996 | 8.93 Million USD | 1.35% |
1995 | 8.81 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 11.77 Million USD | -0.24% |
2023 Q4 | 11.79 Million USD | -23.11% |
2023 Q3 | 15.34 Million USD | -3.31% |
2023 Q1 | 15.57 Million USD | -3.05% |
2023 Q2 | 15.86 Million USD | 1.86% |
2022 Q3 | 14.1 Million USD | -15.41% |
2022 Q2 | 16.67 Million USD | 5.48% |
2022 Q1 | 15.81 Million USD | -13.81% |
2022 FY | 62.66 Million USD | -5.27% |
2022 Q4 | 16.06 Million USD | 13.9% |
2021 Q4 | 18.34 Million USD | 7.07% |
2021 FY | 66.15 Million USD | 14.68% |
2021 Q3 | 17.13 Million USD | 12.7% |
2021 Q1 | 15.47 Million USD | -6.86% |
2021 Q2 | 15.2 Million USD | -1.75% |
2020 Q1 | 14.92 Million USD | 10.72% |
2020 Q3 | 12.58 Million USD | -7.23% |
2020 Q4 | 16.61 Million USD | 32.01% |
2020 FY | 57.68 Million USD | 24.42% |
2020 Q2 | 13.56 Million USD | -9.08% |
2019 FY | 46.36 Million USD | 17.43% |
2019 Q3 | 11.59 Million USD | 3.3% |
2019 Q1 | 10.06 Million USD | -12.87% |
2019 Q4 | 13.47 Million USD | 16.24% |
2019 Q2 | 11.22 Million USD | 11.47% |
2018 Q3 | 9.9 Million USD | 18.5% |
2018 Q1 | 9.65 Million USD | -1.02% |
2018 FY | 39.47 Million USD | 10.01% |
2018 Q4 | 11.55 Million USD | 16.62% |
2018 Q2 | 8.36 Million USD | -13.38% |
2017 Q3 | 8.33 Million USD | -8.41% |
2017 FY | 35.88 Million USD | -1.96% |
2017 Q1 | 8.7 Million USD | -2.04% |
2017 Q2 | 9.09 Million USD | 4.5% |
2017 Q4 | 9.75 Million USD | 17.06% |
2016 Q1 | 9.16 Million USD | -5.13% |
2016 FY | 36.6 Million USD | 10.72% |
2016 Q3 | 9.06 Million USD | -4.37% |
2016 Q4 | 8.88 Million USD | -2.01% |
2016 Q2 | 9.48 Million USD | 3.45% |
2015 FY | 33.06 Million USD | 14.25% |
2015 Q4 | 9.66 Million USD | 9.84% |
2015 Q3 | 8.79 Million USD | 9.88% |
2015 Q2 | 8 Million USD | 21.33% |
2015 Q1 | 6.59 Million USD | -11.49% |
2014 Q4 | 7.45 Million USD | 3.82% |
2014 FY | 28.93 Million USD | 34.09% |
2014 Q1 | 6.53 Million USD | -9.4% |
2014 Q2 | 7.76 Million USD | 18.87% |
2014 Q3 | 7.18 Million USD | -7.55% |
2013 FY | 21.57 Million USD | 6.81% |
2013 Q4 | 7.21 Million USD | 48.18% |
2013 Q2 | 4.52 Million USD | -9.09% |
2013 Q3 | 4.86 Million USD | 7.57% |
2013 Q1 | 4.97 Million USD | 1.79% |
2012 Q3 | 4.37 Million USD | -12.0% |
2012 Q4 | 4.88 Million USD | 11.71% |
2012 Q2 | 4.97 Million USD | 0.0% |
2012 FY | 20.2 Million USD | 0.0% |
2011 Q1 | 6.04 Million USD | 0.84% |
2010 FY | 23.29 Million USD | -2.04% |
2010 Q4 | 5.99 Million USD | 2.99% |
2010 Q3 | 5.82 Million USD | -3.21% |
2010 Q1 | 5.45 Million USD | -7.11% |
2010 Q2 | 6.01 Million USD | 10.32% |
2009 FY | 23.78 Million USD | 0.0% |
2009 Q4 | 5.87 Million USD | -0.59% |
2009 Q3 | 5.9 Million USD | 0.74% |
2009 Q2 | 5.86 Million USD | 0.0% |
2006 Q3 | 5.59 Million USD | 10.0% |
2006 Q4 | 5.63 Million USD | 0.74% |
2006 Q2 | 5.08 Million USD | -8.16% |
2006 Q1 | 5.54 Million USD | 12.14% |
2006 FY | 21.86 Million USD | 12.81% |
2005 Q3 | 4.86 Million USD | 5.49% |
2005 Q2 | 4.61 Million USD | -7.24% |
2005 FY | 19.38 Million USD | 4.6% |
2005 Q1 | 4.97 Million USD | 0.0% |
2005 Q4 | 4.94 Million USD | 1.61% |
2004 FY | 18.53 Million USD | 11.84% |
2003 FY | 16.57 Million USD | 17.26% |
2002 FY | 14.13 Million USD | 0.0% |
2001 Q1 | 3.08 Million USD | -3.14% |
2001 Q2 | 3.07 Million USD | -0.41% |
2001 Q3 | 3.1 Million USD | 1.15% |
2000 Q4 | 3.18 Million USD | 4.34% |
2000 FY | 12.25 Million USD | 5.08% |
2000 Q3 | 3.05 Million USD | 3.93% |
2000 Q2 | 2.93 Million USD | -4.43% |
2000 Q1 | 3.07 Million USD | 2.37% |
1999 FY | 11.66 Million USD | 5.22% |
1999 Q4 | 3 Million USD | 2.79% |
1999 Q2 | 2.97 Million USD | 0.0% |
1999 Q3 | 2.92 Million USD | -1.63% |
1998 FY | 11.08 Million USD | 11.69% |
1997 FY | 9.92 Million USD | 11.02% |
1996 FY | 8.93 Million USD | 1.35% |
1995 FY | 8.81 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Bio Medica Corporation | 913 Thousand USD | -6317.41% |
Arrayit Corporation | 4.37 Million USD | -1238.518% |
Atlantic International Corp. | - USD | -Infinity% |
Biocept, Inc. | 25.85 Million USD | -126.587% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 15.29 Million USD | -283.048% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.207% |
HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -820.341% |
iMD Companies, Inc. | - USD | -Infinity% |
IDenta Corp. | 1.05 Million USD | -5471.653% |
Interpace Biosciences, Inc. | 40.21 Million USD | -45.698% |
Integrative Health Technologies, Inc. | 447.49 Thousand USD | -12992.979% |
InVitro International | 792.62 Thousand USD | -7291.986% |
Lumos Diagnostics Holdings Limited | 11.13 Million USD | -426.376% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 7.22 Million USD | -711.034% |
NovelStem International Corp. | 12 Thousand USD | -488157.908% |
Optigenex Inc. | 465.97 Thousand USD | -12473.975% |
PharmChem, Inc. | 6.01 Million USD | -874.501% |
Proteome Sciences plc | 6.4 Million USD | -815.391% |
Response Genetics, Inc | 18.04 Million USD | -224.784% |
Rennova Health, Inc. | 13.03 Million USD | -349.449% |
RushNet, Inc. | 1.78 Million USD | -3177.119% |
ScreenPro Security Inc. | 1.91 Million USD | -2961.013% |
Stella Diagnostics Inc. | - USD | -Infinity% |
StageZero Life Sciences Ltd. | 3.79 Million USD | -1443.868% |
Todos Medical Ltd. | 7.69 Million USD | -661.416% |